4.8 Article

SERS Multiplex Profiling of Melanoma Circulating Tumor Cells for Predicting the Response to Immune Checkpoint Blockade Therapy

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

A digital single-molecule nanopillar SERS platform for predicting and monitoring immune toxicities in immunotherapy

Junrong Li et al.

Summary: The study develops a digital nanopillar SERS platform for real-time single cytokine counting and dynamic tracking of immune toxicities in cancer patients receiving immune checkpoint inhibitor treatment. By predicting cytokine concentrations, the platform demonstrates capability to identify patients at higher risk for developing severe immune toxicities.

NATURE COMMUNICATIONS (2021)

Article Oncology

Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies

Zhaoli Tan et al.

Summary: The study investigates the role of PD-L1 expression on circulating tumor cells in predicting and monitoring response to PD-1/PD-L1 blockade immunotherapies in advanced cancer patients. Results suggest that PD-L1-high-expression CTCs serve as a predictive biomarker and prognostic factor in patients treated with anti-PD-1/PD-L1 monoclonal antibodies, indicating its potential as a clinical biomarker for immunotherapy.

ONCOLOGIST (2021)

Article Biochemical Research Methods

Simultaneous single-cell phenotype analysis of hepatocellular carcinoma CTCs using a SERS-aptamer based microfluidic chip

Rongke Gao et al.

Summary: A novel strategy for capturing and analyzing circulating tumor cells (CTCs) at the single-cell level using surface-enhanced Raman scattering (SERS) was developed, achieving up to 84% capture efficiency and 95% purity. The approach successfully identified HCC cell subtypes, demonstrating potential for cancer diagnosis and prognosis evaluation.

LAB ON A CHIP (2021)

Article Biochemical Research Methods

Inertial focusing of circulating tumor cells in whole blood at high flow rates using the microfluidic CTCKey™ device for CTC enrichment

Kaylee Judith Smith et al.

Summary: CTCs are rare cells shed from tumors into the blood stream, providing valuable information for treatment decisions. Current technologies face difficulties in isolating enough CTCs for in-depth tumor analysis, prompting the development of the CTCKey(TM) for efficient focusing of CTCs in whole blood.

LAB ON A CHIP (2021)

Article Genetics & Heredity

MHC-I genotype and tumor mutational burden predict response to immunotherapy

Aaron M. Goodman et al.

GENOME MEDICINE (2020)

Article Chemistry, Physical

A high-resolution study of in situ surface-enhanced Raman scattering nanotag behavior in biological systems

Jing Wang et al.

JOURNAL OF COLLOID AND INTERFACE SCIENCE (2019)

Article Genetics & Heredity

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert M. Samstein et al.

NATURE GENETICS (2019)

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

Article Multidisciplinary Sciences

Characterising the phenotypic evolution of circulating tumour cells during treatment

Simon Chang-Hao Tsao et al.

NATURE COMMUNICATIONS (2018)

Review Oncology

Monitoring immune-checkpoint blockade: response evaluation and biomarker development

Mizuki Nishino et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Review Biochemistry & Molecular Biology

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Padmanee Sharma et al.

Article Oncology

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Suzanne L. Topalian et al.

CANCER CELL (2015)

Review Oncology

Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy

Xiangjiao Meng et al.

CANCER TREATMENT REVIEWS (2015)

Review Chemistry, Multidisciplinary

SERS Nanoparticles in Medicine: From Label-Free Detection to Spectroscopic Tagging

Lucas A. Lane et al.

CHEMICAL REVIEWS (2015)

Article Medicine, General & Internal

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

D. T. Le et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Chemistry, Analytical

BSA-Coated Nanoparticles for Improved SERS-Based Intracellular pH Sensing

Xiao-Shan Zheng et al.

ANALYTICAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Paul C. Tumeh et al.

NATURE (2014)

Article Biochemical Research Methods

Microfluidic, marker-free isolation of circulating tumor cells from blood samples

Nezihi Murat Karabacak et al.

NATURE PROTOCOLS (2014)

Article Medicine, General & Internal

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

Alexandra Snyder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Oncology

The Ludwig Institute for Cancer Research Melbourne Melanoma Cell Line Panel

Andreas Behren et al.

PIGMENT CELL & MELANOMA RESEARCH (2013)